MacroGenics | MGNX - Bénéfice Avant Impôts

Prix De L'Action
2.86
Variation Quotidienne
-0.04 -1.38%
Mensuellement
63.43%
Annuel
43.36%
Q1 Prévisions
2.77




Bénéfice Avant Impôts Changement Date
AbbVie USD 4.38B 1.92B 2025-09
Amgen USD 3.92B 2.35B 2025-09
AstraZeneca USD 3.24B 117M 2025-09
Biogen USD 557.3M 186.7M 2025-09
Bristol-Myers Squibb USD 3.11B 1.34B 2025-09
Daiichi Sankyo JPY 106.73B 48.96B 2025-12
Eli Lilly USD 7.23B 456M 2025-09
Genmab DKK 55M 427M 2025-12
Geron USD -31.14M 12.72M 2025-12
Gilead Sciences USD 3.64B 1.21B 2025-09
J&J USD 4.97B 2.53B 2025-12
Karyopharm Therapeutics USD -30.89M 1.16M 2024-12
MacroGenics USD -14.93M 31.75M 2025-12
Merck USD 6.74B 22M 2025-09
Pfizer USD 3.33B 290M 2025-09
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.76B 244.6M 2025-09
Roche Holding CHF 4.79B 3.01B 2025-06
Xencor USD -4.27M 1.76M 2025-12